David Cole

David Cole has a diverse work experience in the field of research and molecular science. David is currently working as the Head of Research and Head of Molecular Science at Accession Therapeutics Limited since August 2021. Prior to this, they held the role of Associate Director of Disease Biology Oncology and Collaboration and Discovery Research Lead at Immunocore from December 2016 to August 2021. David also has experience working at Cardiff University where they served as a Wellcome Trust Fellow, Leverhulm Research Fellow, and Postdoctoral Research Associate. In addition, they are an Honorary Professor at Cardiff University since April 2023. David Cole's work primarily focuses on understanding T-cell recognition during infectious disease, cancer, and autoimmunity.

David Cole completed their Bachelor of Science (BS) degree in Biology, General at Brunel University London from 1999 to 2003. Following this, they pursued a Doctor of Philosophy (PhD) degree in Molecular Immunology at the University of Oxford, completing it from 2003 to 2006.